Skip to main content
SpringerLink
Log in

MCP-1 and CCR2 gene polymorphisms in Parkinson’s disease in a Han Chinese cohort

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Monocyte chemoattractant protein-1 (MCP-1) and its receptor CC chemokine receptor-2 (CCR2) play important roles in neuroinflammation and they have been shown to be involved in Parkinson’s disease (PD) pathogenesis. In addition, several studies have suggested a role for the MCP-1 and CCR2 genotypes in cognitive impairment and depression, which are common non-motor symptoms in PD patients. In this study, a cohort of 521 PD patients and 556 cases of healthy controls were recruited to investigate the association between the MCP-1 2518A/G (rs1064211) and CCR2 V64I (rs1799864) gene polymorphisms and PD risk in the Chinese population. We also analyze the influence of these genotypes on the cognitive function and depression in PD patients by comparing Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Wechsler Adult Intelligence Scale-Chinese Revision (WAIS-RC), Wechsler Memory Scale-Chinese Revision (WMS-RC) and Hamilton Depression Rating Scale (HAMD) ratings in 217 PD patients. Our results showed no significant differences in the genotype frequency between the PD group and the control group (P > 0.05). In addition, we also failed to find an influence of the MCP-1 and CCR2 genotypes on MMSE scores, MoCA scores, WAIS-RC scores, WMS-RC scores and HAMD scores in PD patients (P > 0.05). The MCP-1 and CCR2 gene polymorphisms may not be genetic risk factors for PD in the Han Chinese population, and they do not appear to influence cognitive function and depression in PD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kannarkat GT, Boss JM, Tansey MG (2013) The role of innate and adaptive immunity in Parkinson’s disease. J Parkinsons Dis 3:493–514

    PubMed Central  PubMed  Google Scholar 

  2. Amor S, Peferoen LA, Vogel DY, Breur M, van der Valk P, Baker D, van Noort JM (2013) Inflammation in neurodegenerative diseases—an update. Immunology 142:151–166

    Article  Google Scholar 

  3. Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G (2001) Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 22:147–184

    Article  CAS  PubMed  Google Scholar 

  4. Bose S, Cho J (2013) Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. Arch Pharm Res 36:1039–1050

    Article  CAS  PubMed  Google Scholar 

  5. Conductier G, Blondeau N, Guyon A, Nahon JL, Rovere C (2010) The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 224:93–100

    Article  CAS  PubMed  Google Scholar 

  6. Pattarini R, Smeyne RJ, Morgan JI (2007) Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson’s disease. Neuroscience 145:654–668

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Reale M, Iarlori C, Thomas A, Gambi D, Perfetti B, Di Nicola M, Onofrj M (2009) Peripheral cytokines profile in Parkinson’s disease. Brain Behav Immun 23:55–63

    Article  CAS  PubMed  Google Scholar 

  8. Lindqvist D, Hall S, Surova Y, Nielsen HM, Janelidze S, Brundin L, Hansson O (2013) Cerebrospinal fluid inflammatory markers in Parkinson’s disease–associations with depression, fatigue, and cognitive impairment. Brain Behav Immun 33:183–189

    Article  CAS  PubMed  Google Scholar 

  9. Nishimura M, Kuno S, Mizuta I, Ohta M, Maruyama H, Kaji R, Kawakami H (2003) Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson’s disease. Mov Disord 18:953–955

    Article  PubMed  Google Scholar 

  10. Pola R, Flex A, Gaetani E, Proia AS, Papaleo P, Di Giorgio A et al (2004) Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer’s disease in Italians. Exp Gerontol 39:1249–1252

    Article  CAS  PubMed  Google Scholar 

  11. Galimberti D, Fenoglio C, Lovati C, Gatti A, Guidi I, Venturelli E et al (2004) CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer’s disease. J Neurol Sci 225:79–83

    Article  CAS  PubMed  Google Scholar 

  12. Pae CU, Chung KI, Kim JJ, Yu HS, Lee CU, Lee SJ et al (2004) Monocyte chemoattractant protein-1 promoter -2518 polymorphism and schizophrenia in the Korean population. Psychiatr Genet 14:65–67

    Article  PubMed  Google Scholar 

  13. Daniel SE, Lees AJ (1993) Parkinson’s Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 39:165–172

    CAS  PubMed  Google Scholar 

  14. Nie K, Zhang Y, Gan R, Wang L, Zhao J, Huang Z et al (2013) Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson’s disease with cognitive impairment in the Han Chinese population. Neurosci Lett 541:111–115

    Article  CAS  PubMed  Google Scholar 

  15. Guyon A, Skrzydelski D, De Giry I, Rovere C, Conductier G, Trocello JM et al (2009) Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience 162:1072–1080

    Article  CAS  PubMed  Google Scholar 

  16. Huerta C, Alvarez V, Mata IF, Coto E, Ribacoba R, Martinez C et al (2004) Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer’s and Parkinson’s disease. Neurosci Lett 370:151–154

    Article  CAS  PubMed  Google Scholar 

  17. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844

    Article  PubMed  Google Scholar 

  18. Westin K, Buchhave P, Nielsen H, Minthon L, Janciauskiene S, Hansson O (2012) CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer’s disease. PLoS One 7:e30525

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Harries LW, Bradley-Smith RM, Llewellyn DJ, Pilling LC, Fellows A, Henley W et al (2012) Leukocyte CCR2 expression is associated with mini-mental state examination score in older adults. Rejuvenation Res 15:395–404

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Zhang R, Miller RG, Madison C, Jin X, Honrada R, Harris W et al (2013) Systemic immune system alterations in early stages of Alzheimer’s disease. J Neuroimmunol 256:38–42

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Galimberti D, Fenoglio C, Lovati C, Venturelli E, Guidi I, Corra B et al (2006) Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease. Neurobiol Aging 27:1763–1768

    Article  CAS  PubMed  Google Scholar 

  22. Porcellini E, Ianni M, Carbone I, Franceschi M, Licastro F (2013) Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease. Immun Ageing 10:6

    Article  PubMed Central  PubMed  Google Scholar 

  23. Fenoglio C, Galimberti D, Lovati C, Guidi I, Gatti A, Fogliarino S et al (2004) MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging 25:1169–1173

    Article  CAS  PubMed  Google Scholar 

  24. Combarros O, Infante J, Llorca J, Berciano J (2004) No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer’s disease. Neurosci Lett 360:25–28

    Article  CAS  PubMed  Google Scholar 

  25. Khorram Khorshid HR, Manoochehri M, Nasehi L, Ohadi M, Rahgozar M, Kamali R (2012) Ccr2-64i and Ccr5 Delta32 Polymorphisms in Patients with Late-Onset Alzheimer’s disease; A Study from Iran (Ccr2-64i And Ccr5 Delta32 Polymorphisms in Alzheimer’s disease). Iran J Basic Med Sci 15:937–944

    PubMed Central  PubMed  Google Scholar 

  26. van Zuiden M, Heijnen CJ, van de Schoot R, Amarouchi K, Maas M, Vermetten E et al (2011) Cytokine production by leukocytes of military personnel with depressive symptoms after deployment to a combat-zone: a prospective, longitudinal study. PLoS One 6:e29142

    Article  PubMed Central  PubMed  Google Scholar 

  27. Piletz JE, Halaris A, Iqbal O, Hoppensteadt D, Fareed J, Zhu H et al (2009) Pro-inflammatory biomakers in depression: treatment with venlafaxine. World J Biol Psychiatry 10:313–323

    Article  PubMed  Google Scholar 

  28. Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH et al (2008) A detailed examination of cytokine abnormalities in major depressive disorder. Eur Neuropsychopharmacol 18:230–233

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O et al (2007) Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol 2007:76396

    Article  PubMed Central  PubMed  Google Scholar 

  30. Altamura AC, Mundo E, Cattaneo E, Pozzoli S, Dell’osso B, Gennarelli M et al (2010) The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study. Neuroimmunomodulation 17:126–131

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank all the subjects who kindly agreed to participate in this study. This work is supported by grants from the National Natural Science Foundation of China (No. 81371401, No. 30801219), Natural Science Foundation of Guangdong Province, China (No. S2013010014033), Science and Technology Planning Project of Guangdong Province, China (No. 2013B021800199) and Science and Technology Program of Guangzhou, China (No. 2014J4100083, No. 2013J4100068).

Conflict of interest

The authors declare that they have no conflict of interest. Written informed consents were obtained from all subjects before their participation. The study was approved by the Ethics Committee of Guangdong General Hospital.

Author information

Authors and Affiliations

  1. Department of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Rd II, Guangzhou, 510080, Guangdong Province, People’s Republic of China

    Liang Gao, Hongmei Tang, Kun Nie, Limin Wang, Jiehao Zhao, Rong Gan, Jing Huang, Shujun Feng, Ruiming Zhu, Zhenpeng Duan, Youwen Zhang, Xin Zhao, Yuhu Zhang & Lijuan Wang

Authors
  1. Liang Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongmei Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kun Nie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Limin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jiehao Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rong Gan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jing Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shujun Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ruiming Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Zhenpeng Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Youwen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Xin Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yuhu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Lijuan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lijuan Wang.

Additional information

L. Gao, H. Tang have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, L., Tang, H., Nie, K. et al. MCP-1 and CCR2 gene polymorphisms in Parkinson’s disease in a Han Chinese cohort. Neurol Sci 36, 571–576 (2015). https://doi.org/10.1007/s10072-014-1990-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-014-1990-3

Keywords

Search

Navigation